Skip to content
Screener

Embecta Corp. EMBC Q1 2026 earnings

Reported February 5, 2026 · Before market open

Revenue$261.2MBeat by $3.1M
EPS$0.71Beat by $0.04
Revenue estimate$258.1M
EPS estimate$0.67

Next report

Nov 24, 2026 (in 2 months)
Revenue estimate$269.7M
EPS estimate$0.31

Financials

Q1 2026

Income statement

See full
Revenue$261.2M-0.3%
Gross profit$161.7M+2.9%
Operating income$83.3M+190%
Net income$44.1M—
EPS (diluted)$0.74—

Balance sheet

See full
Cash & equivalents$204.4M-5.7%
Total debt$1.4B-11.4%
Total equity-$613.1M+20.3%
Total assets$1.1B-7.5%

Cash flow

See full
Operating cash flow$17.2M+425%
CapEx$600.0K-60.0%
Free cash flow$16.6M+344%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$703.44M-41.4%
Enterprise value$1.91B-25.9%
P/E5×-15.6×
P/S0.7×-0.4×

Profitability

See full
Gross margin63.1%-0.7pp
Operating margin27.5%+13.9pp
Net margin12.9%+7.7pp
FCF margin19.1%+16.5pp

Returns & leverage

See full
Current ratio2.6×+0.4×

Segments

By product

See full
Pen Needles$185.5M-2.9%
Safety$37.3M+9.1%
Syringes$30.7M+8.1%
Contract Manufacturing$4.1M-14.6%

FAQ

When did Embecta Corp. report Q1 2026 earnings?
Embecta Corp. (EMBC) reported Q1 2026 earnings on February 5, 2026 before market open.
What were Embecta Corp.'s Q1 2026 revenue and EPS?
Embecta Corp. reported revenue of $261.2M and eps of $0.71 for Q1 2026.
Did Embecta Corp. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $258.1M by $3.1M. EPS beat the consensus estimate of $0.67 by $0.04.
How did Embecta Corp.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.3% from $261.9M a year earlier and eps grew 9.2% from $0.65.
Where can I find Embecta Corp.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001872789-26-000005) and the 10-Q periodic report (0001872789-26-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.